Falcon Genomics Inc Profile last edited on: 2/18/14
CAGE: 47W14
UEI: WXS9BFSCDMM6
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
160 North Craig Street Suite 222
Pittsburgh, PA 15213
Pittsburgh, PA 15213
| (412) 802-6236 |
| falcongenomics@verizon.net |
| www.falcongenomics.com |
Location: Single
Congr. District: 18
County: Allegheny
Congr. District: 18
County: Allegheny
Public Profile
Falcon Genomics, Inc. provides technologies for the diagnosis of cancer patients and the formulation of therapeutic strategies. The companyâs technology platform, the Cancer BioChip System (CBCS), identifies compounds that are required for anchorage-independent growth of patient cells. Its CBCS is used for cancer therapeutic target identification and validation. Falcon Genomics also provides CBCS services that limit the risks taken by its customers in adopting its technology. The company serves pharmaceutical companies and research institutions seeking a platform for the identification of cancer target
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2010 | 1 | NIH | $269,640 | |
| Project Title: Development Of A Test Cancer Biochip For The Cancer Biochip System | ||||
Key People / Management
Rula A Abbud-Antaki -- President
Company News
There are no news available.
